Comparative study of cognitive impairment between medicated and medication-free patients with remitted major depression: Class-specific influence by tricyclic antidepressants and newer antidepressants

Psychiatry Research

Volumn 218, Issue 1-2, 2014, Pages 101-105

  Nagane, Akiko ^a,b,c   Baba, Hajime ^a,d   Nakano, Yoshiyuki ^a,d   Maeshima, Hitoshi ^a,d   Hukatsu, Mana ^c   Ozawa, Kazuhiro ^a   Suzuki, Toshihito ^a,d   Arai, Heii ^a,d  

^a Juntendo University Hospital   (Japan)

^b Shumeikai Minami saitama Hospital   (Japan)

^c Shumeikai Izumi Clinic   (Japan)

^d JUNTENDO UNIVERSITY   (Japan)

Author keywords

Antidepressant; Cognition; Depression; Executive function; Medication; Memory; Remission

Indexed keywords

SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL PERFORMANCE; PRIORITY JOURNAL; REMISSION; STROOP TEST; VERBAL MEMORY; VISUAL MEMORY; WECHSLER MEMORY SCALE; AGED; COGNITION; COGNITION DISORDERS; COMPLICATION; DEPRESSIVE DISORDER, MAJOR; DRUG EFFECTS; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; COGNITION; COGNITION DISORDERS; DEPRESSIVE DISORDER, MAJOR; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SEROTONIN UPTAKE INHIBITORS;

EID: 84902077955     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.04.013     Document Type: Article

References (21)

1. Amado-Boccara I., Gougoulis N., Poirier Littre M.F., Galinowski A., Loo H. Effects of antidepressants on cognitive functions: a review. Neuroscience and Biobehavioral Reviews 1995, 19:479-493.
2. Austin M.P., Mitchell P., Goodwin G.M. Cognitive deficits in depression: possible implications for functional neuropathology. British Journal of Psychiatry: Journal of Mental Science 2001, 178:200-206.
3. Baba K., Baba H., Noguchi I., Arai R., Suzuki T., Mimura M., Arai H. Executive dysfunction in remitted late-life depression: Juntendo University Mood Disorder Projects (JUMP). Journal of Neuropsychiatry and Clinical Neurosciences 2010, 22:70-74.
4. Gallassi R., Di Sarro R., Morreale A., Amore M. Memory impairment in patients with late-onset major depression: the effect of antidepressant therapy. Journal of Affective Disorders 2006, 91:243-250.
5. Golden C.J. Stroop Color and Word Test: A Manual for Clinical and Experimental Uses 1978, stoelting, Chicago.
6. Gorenstein C., de Carvalho S.C., Artes R., Moreno R.A., Marcourakis T. Cognitive performance in depressed patients after chronic use of antidepressants. Psychopharmacology 2006, 185:84-92.
7. Halvorsen M., Waterloo K., Sundet K., Eisemann M., Wang C.E. Verbal learning and memory in depression: a 9-year follow-up study. Psychiatry Research 2011, 188:350-354.
8. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960, 23:56-62.
9. Inagaki A., Inada T. Dose equivalence of Psychotropic Drugs Part 18. Japanese Journal of Clinical Psychopharmacology 2006, 9:1443-1447.
10. Maeshima H., Baba H., Nakano Y., Satomura E., Namekawa Y., Takebayashi N., Suzuki T., Mimura M., Arai H. Residual memory dysfunction in recurrent major depressive disorder-a longitudinal study from Juntendo University Mood Disorder Project. Journal of Affective Disorders 2012, 143:84-88.
11. Marcos T., Salamero M., Gutierrez F., Catalan R., Gasto C., Lazaro L. Cognitive dysfunctions in recovered melancholic patients. Journal of Affective Disorders 1994, 32:133-137.
12. Nakano Y., Baba H., Maeshima H., Kitajima A., Sakai Y., Baba K., Suzuki T., Mimura M., Arai H. Executive dysfunction in medicated, remitted state of major depression. Journal of Affective Disorders 2008, 111:46-51.
13. Owens M.J., Morgan W.N., Plott S.J., Nemeroff C.B. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. Journal of Pharmacology and Experimental Therapeutics 1997, 283:1305-1322.
14. Paelecke-Habermann Y., Pohl J., Leplow B. Attention and executive functions in remitted major depression patients. Journal of Affective Disorders 2005, 89:125-135.
15. Poirier M.F., Galinowski A., Amado I., Longevialle R., Bourdel M.C., Tournoux A., Serre C., Loo H. Double-blind comparative study of the action of repeated administration of milnacipran versus placebo on cognitive functions in healthy volunteers. Human Psychopharmacology 2004, 19:1-7.
16. Porter R.J., Gallagher P., Thompson J.M., Young A.H. Neurocognitive impairment in drug-free patients with major depressive disorder. British Journal of Psychiatry: Journal of Mental Science 2003, 182:214-220.
17. Schmitt J.A., Kruizinga M.J., Riedel W.J. Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors. Journal of Psychopharmacology 2001, 15:173-179.
18. Vythilingam M., Vermetten E., Anderson G.M., Luckenbaugh D., Anderson E.R., Snow J., Staib L.H., Charney D.S., Bremner J.D. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biological Psychiatry 2004, 56:101-112.
19. Wagner S., Doering B., Helmreich I., Lieb K., Tadic A. A meta-analysis of executive dysfunctions in unipolar major depressive disorder without psychotic symptoms and their changes during antidepressant treatment. Acta Psychiatrica Scandinavica 2012, 125:281-292.
20. Wechsler D. Wechsler Memory Scale-Revised 1987, Psychological Corporation Harcourt Brace Jovanovich, New York.
21. Weiland-Fiedler P., Erickson K., Waldeck T., Luckenbaugh D.A., Pike D., Bonne O., Charney D.S., Neumeister A. Evidence for continuing neuropsychological impairments in depression. Journal of Affective Disorders 2004, 82:253-258.